EP Patent

EP1005327A1 — Targeted liposomal constructs for diagnostic and therapeutic uses

Assigned to SDG Technology Inc · Expires 2000-06-07 · 26y expired

What this patent protects

This invention provides a liposomal construct for delivering a diagnostic or therapeutic agent to a mammal comprising a liposomal carrier, a diagnostic or therapeutic agent entrapped within or associated with said liposomal carrier and a sequestering agent distributed within said…

USPTO Abstract

This invention provides a liposomal construct for delivering a diagnostic or therapeutic agent to a mammal comprising a liposomal carrier, a diagnostic or therapeutic agent entrapped within or associated with said liposomal carrier and a sequestering agent distributed within said liposomal carrier to reduce leakage of the diagnostic or therapeutic agent from the liposomal construct prior to delivery.

Drugs covered by this patent

Patent Metadata

Patent number
EP1005327A1
Jurisdiction
EP
Classification
—
Expires
2000-06-07
Drug substance claim
No
Drug product claim
No
Assignee
SDG Technology Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.